Indian stocks: Visit www.stage2stocks.com →

DaVita Inc.

Stage 3 · Topping · week 9

As of Oct 22, 2026, DaVita is in Stage 3, the topping phase, now in week 9 (since Aug 25, 2026). It closed at $186.10, 22.8% below its 52-week high and above its 200-day average, which is rising.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. More about the company

$186.10
+5.25% today
$11.9B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is DVA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 50w
S4 15w
S4 26w
S2 24w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 6w → S3 5w → S4 5w → S1 3w → S2 50w → S3 5w → S2 6w → S3 5w → S4 15w → S1 3w → S4 26w → S1 4w → S2 24w → S3 8w current
Total tracked: 165 weeks across 14 stage runs.

DVA among Medical Care Facilities15th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…15DVAStage 3 · wk 984+1.6%
vs 52W High
-22.8%
$103.87 lo$240.96 hi
22.8% below 52W high, weakening from peak
The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.
Stage Maturity
Week 9
1w13w26w
Week 9, distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
6.5%
200 DMA: $174.71 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
1.41x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+1.6%
3M
-21.0%
6M
+20.0%
YTD
+62.5%
1Y
+44.9%
Scan Membership
Breakout Watch
Latest: 2025-01-23
8 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S3
Wk 9 · Vol 1.41x
2026-10-21S3
Wk 9 · Vol 1.15x
2026-10-20S3
Wk 8 · Vol 3.23x
2026-10-19S3
Wk 8 · Vol 0.49x
2026-10-16S3
Wk 8 · Vol 0.74x
2026-10-15S3
Wk 8 · Vol 0.83x
2026-10-14S3
Wk 8 · Vol 0.56x
2026-10-13S3
Wk 7 · Vol 0.49x
2026-10-12S3
Wk 7 · Vol 0.73x
2026-10-09S3
Wk 7 · Vol 0.46x
2026-10-08S3
Wk 7 · Vol 0.72x
2026-10-07S3
Wk 7 · Vol 0.80x
Moving averages & range
50 DMA
$180.45
200 DMA
$174.71
52W High
$240.96
52W Low
$103.87
5D Low
$175.35
Resistance levels (recent highs)
20d High
$189.16
60d High
$240.09
120d High
$240.96
250d High
$240.96
Next resistance
+1.6%
to 20d High
P/E (TTM)
15.7
Forward 10.9
Earnings Growth (YoY)
+55.8%
Revenue +5.2%
ROE
+88.5%
Profit margin +6.0%
Dividend Yield
0.00%
P/B -15.6

DaVita: quick answers

What stage is DaVita in?

As of Oct 22, 2026, DaVita (DVA) is in Stage 3, the topping phase. It entered Stage 3 on Aug 25, 2026 and is in week 9. What the four stages mean

Is DaVita in an uptrend?

Its uptrend has stalled. DaVita is in Stage 3, the topping phase that follows an advance. It trades 6.5% above its 200-day average, which is rising.

How far is DaVita from its 52-week high?

DaVita closed at $186.10 on Oct 22, 2026, 22.8% below its 52-week high of $240.96. Its 52-week low is $103.87.

How has DaVita performed over the past year?

As of Oct 22, 2026, DaVita is up 44.9% over the past year and up 62.5% so far in 2026.

Which sector and industry is DaVita in?

DaVita is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.